PROS1 and viral infectious disease: CQ was found to have limited potency in inhibiting viral infection of human lung cells that express co-receptor TMPRSS2, such as Calu-3, which facilitates S protein priming and mediates viral entry via plasma membrane fusion instead of endocytosis [24].